1. Home
  2. VTSI vs IFRX Comparison

VTSI vs IFRX Comparison

Compare VTSI & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTSI
  • IFRX
  • Stock Information
  • Founded
  • VTSI 1993
  • IFRX 2007
  • Country
  • VTSI United States
  • IFRX Germany
  • Employees
  • VTSI N/A
  • IFRX N/A
  • Industry
  • VTSI Miscellaneous manufacturing industries
  • IFRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTSI Consumer Discretionary
  • IFRX Health Care
  • Exchange
  • VTSI Nasdaq
  • IFRX Nasdaq
  • Market Cap
  • VTSI 67.3M
  • IFRX 65.8M
  • IPO Year
  • VTSI N/A
  • IFRX 2017
  • Fundamental
  • Price
  • VTSI $6.07
  • IFRX $0.79
  • Analyst Decision
  • VTSI Strong Buy
  • IFRX Strong Buy
  • Analyst Count
  • VTSI 1
  • IFRX 4
  • Target Price
  • VTSI $7.00
  • IFRX $7.75
  • AVG Volume (30 Days)
  • VTSI 72.8K
  • IFRX 875.8K
  • Earning Date
  • VTSI 08-11-2025
  • IFRX 08-07-2025
  • Dividend Yield
  • VTSI N/A
  • IFRX N/A
  • EPS Growth
  • VTSI N/A
  • IFRX N/A
  • EPS
  • VTSI 0.19
  • IFRX N/A
  • Revenue
  • VTSI $26,164,645.00
  • IFRX $140,242.00
  • Revenue This Year
  • VTSI $9.92
  • IFRX N/A
  • Revenue Next Year
  • VTSI $16.54
  • IFRX $6,309.47
  • P/E Ratio
  • VTSI $31.97
  • IFRX N/A
  • Revenue Growth
  • VTSI N/A
  • IFRX 30.90
  • 52 Week Low
  • VTSI $3.57
  • IFRX $0.71
  • 52 Week High
  • VTSI $9.40
  • IFRX $2.82
  • Technical
  • Relative Strength Index (RSI)
  • VTSI 54.39
  • IFRX 34.33
  • Support Level
  • VTSI $5.83
  • IFRX $0.75
  • Resistance Level
  • VTSI $6.41
  • IFRX $0.83
  • Average True Range (ATR)
  • VTSI 0.35
  • IFRX 0.05
  • MACD
  • VTSI -0.08
  • IFRX -0.00
  • Stochastic Oscillator
  • VTSI 36.10
  • IFRX 29.85

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: